Delivery Order SPE2DP20D0002-SPE2DP25F8219
Award Date
6/16/25
Potential Completion Date
6/24/25
Potential Value
$165K
Federal Agency
Medical Supply Chain
Awardee
Teva Pharmaceuticals Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 vaccine, which is a critical product for military immunization programs. The contract has a ceiling value of $660,627.72 and a period of performance ending on June 24, 2025. Teva Pharmaceuticals USA, Inc. has established itself as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $165,156.93, is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. The contract is a firm-fixed-price delivery order with a performance period through March 25, 2025. Teva Pharmaceuticals USA, Inc. is the prime contractor, and there are no...
This firm-fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $825,784.65 contract is for the delivery of Adenovirus Type 4 vaccines, which are critical medical products for military immunization programs. Teva is a key supplier to federal healthcare agencies, including the Department of Veterans Affairs (VA), Department of Defense (DOD),...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 vaccine, a critical medical product for military immunization programs. The contract has a ceiling value of $495,470.79 and a performance period ending on June 24, 2025. Teva Pharmaceuticals USA, Inc. is a key supplier of...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 vaccine, which is critical for military immunization programs. The contract has a ceiling value of $165,156.93 and a period of performance through April 29, 2025. Teva Pharmaceuticals USA, Inc. is the prime contractor, and there are no...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency's Troop Support Medical division to Teva Pharmaceuticals USA, Inc., a foreign-owned pharmaceutical manufacturer, for the delivery of Adenovirus Type 4 vaccine. The $317,609.46 contract has an ultimate completion date of December 3, 2024 and is not set aside for any particular business type. Teva Pharmaceuticals is a major supplier of critical medical products, including vaccines, to various federal...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $158,804.73 contract, which has no set-aside designation, is for the supply of Adenovirus Type 4 A vaccine with a completion date of February 27, 2024. Teva Pharmaceuticals USA, Inc. has been awarded multiple federal contracts and delivery orders from agencies like the Department of Veterans...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $330,313.86, is for the delivery of Adenovirus Type 4 vaccines to support military immunization programs. Teva Pharmaceuticals USA, Inc. is a major supplier of critical pharmaceutical products to federal agencies, including the Department of Veterans Affairs...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $990,941.58, is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. The contract has an ultimate completion date of April 29, 2025. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $158,804.73, is for the delivery of Adenovirus Type 4 vaccine, a critical product that supports military immunization programs. The contract has a period of performance through July 30, 2024 and is a firm-fixed-price type. Teva Pharmaceuticals USA, Inc. has received multiple delivery orders...